DAG-MAG-ΒHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions
Nutrients · 2024
DOI: 10.3390/nu17010149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Valentina Gentili und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Microglia, Amyloid beta-Peptides, Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP).
Abstract (Originalsprache)
Background
A neuroinflammatory disease such as Alzheimer’s disease, presents a significant challenge in neurotherapeutics, particularly due to the complex etiology and allostatic factors, referred to as CNS stressors, that accelerate the development and progression of the disease. These CNS stressors include cerebral hypo-glucose metabolism, hyperinsulinemia, mitochondrial dysfunction, oxidative stress, impairment of neuronal autophagy, hypoxic insults and neuroinflammation. This study aims to explore the efficacy and safety of DAG-MAG-ΒHB, a novel ketone diester, in mitigating these risk factors by sustaining therapeutic ketosis, independent of conventional metabolic pathways.
Methods
We evaluated the intestinal absorption of DAG-MAG-ΒHB and the metabolic impact in human microglial cells. Utilizing the HMC3 human microglia cell line, we examined the compound’s effect on cellular viability, Acetyl-CoA and ATP levels, and key metabolic enzymes under hypoglycemia. Additionally, we assessed the impact of DAG-AG-ΒHB on inflammasome activation, mitochondrial activity, ROS levels, inflammation and phagocytic rates.
Results
DAG-MAG-ΒHB showed a high rate of intestinal absorption and no cytotoxic effect. In vitro, DAG-MAG-ΒHB enhanced cell viability, preserved morphological integrity, and maintained elevated Acetyl-CoA and ATP levels under hypoglycemic conditions. DAG-MAG-ΒHB increased the activity of BDH1 and SCOT, indicating ATP production via a ketolytic pathway. DAG-MAG-ΒHB showed remarkable resilience against low glucose condition by inhibiting NLRP3 inflammasome activation.
Conclusions
In summary, DAG-MAG-ΒHB emerges as a promising treatment for neuroinflammatory conditions. It enhances cellular health under varying metabolic states and exhibits neuroprotective properties against low glucose conditions. These attributes indicate its potential as an effective component in managing neuroinflammatory diseases, addressing their complex progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Department of Chemical, Pharmaceutical, Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
- Management Department, Temple University, Japan Campus, Tokyo 154-0004, Japan.
ORCID-Profile: Valentina Gentili, Giovanna Schiuma, Silvia Beltrami, Sabrina Rizzo, Djidjell Lara, Matteo Marti, Daria Bortolotti, Claudio Trapella, Roberta Rizzo
Förderung
- National Recovery and Resilience Plan (NRRP)
Zitieren
APA
Gentili, V., Schiuma, G., Dilliraj, L. N., Beltrami, S., Rizzo, S., Lara, D., Giovannini, P. P., Marti, M., Bortolotti, D., Trapella, C., Narducci, M., & Rizzo, R. (2024). DAG-MAG-ΒHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions. Nutrients. https://doi.org/10.3390/nu17010149
Vancouver
Gentili V, Schiuma G, Dilliraj LN, Beltrami S, Rizzo S, Lara D, et al. DAG-MAG-ΒHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions. Nutrients. 2024. doi:10.3390/nu17010149
BibTeX
@article{Gentili2024,
author = {Gentili, Valentina and Schiuma, Giovanna and Dilliraj, Latha Nagamani and Beltrami, Silvia and Rizzo, Sabrina and Lara, Djidjell and Giovannini, Pier Paolo and Marti, Matteo and Bortolotti, Daria and Trapella, Claudio and Narducci, Marco and Rizzo, Roberta},
title = {DAG-MAG-ΒHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu17010149}
}
EUVIMED